Skip to main content
PMC home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 2000 Jun;9(6):1137–1148. doi: 10.1110/ps.9.6.1137

Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein.

S Arold 1, F Hoh 1, S Domergue 1, C Birck 1, M A Delsuc 1, M Jullien 1, C Dumas 1
PMCID: PMC2144662  PMID: 10892807

Abstract

The Nef protein of human immunodeficiency virus type I (HIV-1) is an important determinant for the onset of AIDS disease. The self-association properties of HIV-1 Nef are analyzed by chemical cross-linking, dynamic light scattering, equilibrium analytical ultracentrifugation, and NMR spectroscopy. The experimental data show that the HIV-1 Nef core domain forms stable homo-dimers and trimers in solution, but not higher oligomers. These Nef homomers are not covalently linked by disulfide bridges, and the equilibrium between these forms is dependent on the Nef concentration. We further provide the molecular basis for the Nef core dimers and trimers obtained by analysis of crystallographic models. Oligomerization of biological polypeptides is a common tool used to trigger events in cellular signaling and endocytosis, both of which are targeted by Nef. The quaternary structure of Nef may be of physiological importance and may help to connect its cellular targets or to increase affinity of the viral molecule for its ligands. The herein described models for Nef dimers and trimers will allow further mutational studies to elucidate their role in vivo. These results provide novel insight into the structural and functional relationships of this important viral protein. Moreover, the oligomer interface may represent a novel target for the design of antiviral agents.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiken C., Konner J., Landau N. R., Lenburg M. E., Trono D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 1994 Mar 11;76(5):853–864. doi: 10.1016/0092-8674(94)90360-3. [DOI] [PubMed] [Google Scholar]
  2. Arold S., Franken P., Strub M. P., Hoh F., Benichou S., Benarous R., Dumas C. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure. 1997 Oct 15;5(10):1361–1372. doi: 10.1016/s0969-2126(97)00286-4. [DOI] [PubMed] [Google Scholar]
  3. Arold S., O'Brien R., Franken P., Strub M. P., Hoh F., Dumas C., Ladbury J. E. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. Biochemistry. 1998 Oct 20;37(42):14683–14691. doi: 10.1021/bi980989q. [DOI] [PubMed] [Google Scholar]
  4. Barnham K. J., Monks S. A., Hinds M. G., Azad A. A., Norton R. S. Solution structure of a polypeptide from the N terminus of the HIV protein Nef. Biochemistry. 1997 May 20;36(20):5970–5980. doi: 10.1021/bi9629945. [DOI] [PubMed] [Google Scholar]
  5. Baur A. S., Sawai E. T., Dazin P., Fantl W. J., Cheng-Mayer C., Peterlin B. M. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity. 1994 Aug;1(5):373–384. doi: 10.1016/1074-7613(94)90068-x. [DOI] [PubMed] [Google Scholar]
  6. Benichou S., Bomsel M., Bodéus M., Durand H., Douté M., Letourneur F., Camonis J., Benarous R. Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J Biol Chem. 1994 Dec 2;269(48):30073–30076. [PubMed] [Google Scholar]
  7. Bresnahan P. A., Yonemoto W., Ferrell S., Williams-Herman D., Geleziunas R., Greene W. C. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol. 1998 Nov 5;8(22):1235–1238. doi: 10.1016/s0960-9822(07)00517-9. [DOI] [PubMed] [Google Scholar]
  8. Capps G. G., Robinson B. E., Lewis K. D., Zúiga M. C. In vivo dimeric association of class I MHC heavy chains. Possible relationship to class I MHC heavy chain-beta 2-microglobulin dissociation. J Immunol. 1993 Jul 1;151(1):159–169. [PubMed] [Google Scholar]
  9. Carugo O., Argos P. Protein-protein crystal-packing contacts. Protein Sci. 1997 Oct;6(10):2261–2263. doi: 10.1002/pro.5560061021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chen Y. L., Trono D., Camaur D. The proteolytic cleavage of human immunodeficiency virus type 1 Nef does not correlate with its ability to stimulate virion infectivity. J Virol. 1998 Apr;72(4):3178–3184. doi: 10.1128/jvi.72.4.3178-3184.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chothia C., Janin J. Principles of protein-protein recognition. Nature. 1975 Aug 28;256(5520):705–708. doi: 10.1038/256705a0. [DOI] [PubMed] [Google Scholar]
  12. Chowers M. Y., Spina C. A., Kwoh T. J., Fitch N. J., Richman D. D., Guatelli J. C. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol. 1994 May;68(5):2906–2914. doi: 10.1128/jvi.68.5.2906-2914.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Collette Y., Dutartre H., Benziane A., Ramos-Morales, Benarous R., Harris M., Olive D. Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J Biol Chem. 1996 Mar 15;271(11):6333–6341. doi: 10.1074/jbc.271.11.6333. [DOI] [PubMed] [Google Scholar]
  14. Craig H. M., Pandori M. W., Guatelli J. C. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11229–11234. doi: 10.1073/pnas.95.19.11229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cullen B. R. HIV-1 auxiliary proteins: making connections in a dying cell. Cell. 1998 May 29;93(5):685–692. doi: 10.1016/s0092-8674(00)81431-2. [DOI] [PubMed] [Google Scholar]
  16. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 1995 Nov 10;270(5238):988–991. doi: 10.1126/science.270.5238.988. [DOI] [PubMed] [Google Scholar]
  17. Du Z., Lang S. M., Sasseville V. G., Lackner A. A., Ilyinskii P. O., Daniel M. D., Jung J. U., Desrosiers R. C. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell. 1995 Aug 25;82(4):665–674. doi: 10.1016/0092-8674(95)90038-1. [DOI] [PubMed] [Google Scholar]
  18. Franken P., Arold S., Padilla A., Bodeus M., Hoh F., Strub M. P., Boyer M., Jullien M., Benarous R., Dumas C. HIV-1 Nef protein: purification, crystallizations, and preliminary X-ray diffraction studies. Protein Sci. 1997 Dec;6(12):2681–2683. doi: 10.1002/pro.5560061227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Freund J., Kellner R., Houthaeve T., Kalbitzer H. R. Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1. Eur J Biochem. 1994 Apr 15;221(2):811–819. doi: 10.1111/j.1432-1033.1994.tb18795.x. [DOI] [PubMed] [Google Scholar]
  20. Freund J., Kellner R., Konvalinka J., Wolber V., Kräusslich H. G., Kalbitzer H. R. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur J Biochem. 1994 Jul 15;223(2):589–593. doi: 10.1111/j.1432-1033.1994.tb19029.x. [DOI] [PubMed] [Google Scholar]
  21. Fujii Y., Otake K., Fujita Y., Yamamoto N., Nagai Y., Tashiro M., Adachi A. Clustered localization of oligomeric Nef protein of human immunodeficiency virus type 1 on the cell surface. FEBS Lett. 1996 Oct 21;395(2-3):257–261. doi: 10.1016/0014-5793(96)01048-4. [DOI] [PubMed] [Google Scholar]
  22. Gaedigk-Nitschko K., Schön A., Wachinger G., Erfle V., Kohleisen B. Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease. FEBS Lett. 1995 Jan 9;357(3):275–278. doi: 10.1016/0014-5793(94)01370-g. [DOI] [PubMed] [Google Scholar]
  23. Garcia J. V., Miller A. D. Retrovirus vector-mediated transfer of functional HIV-1 regulatory genes. AIDS Res Hum Retroviruses. 1994 Jan;10(1):47–52. doi: 10.1089/aid.1994.10.47. [DOI] [PubMed] [Google Scholar]
  24. Garcia K. C., Teyton L., Wilson I. A. Structural basis of T cell recognition. Annu Rev Immunol. 1999;17:369–397. doi: 10.1146/annurev.immunol.17.1.369. [DOI] [PubMed] [Google Scholar]
  25. Geyer M., Munte C. E., Schorr J., Kellner R., Kalbitzer H. R. Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein. J Mol Biol. 1999 May 28;289(1):123–138. doi: 10.1006/jmbi.1999.2740. [DOI] [PubMed] [Google Scholar]
  26. Greenberg M. E., Bronson S., Lock M., Neumann M., Pavlakis G. N., Skowronski J. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 1997 Dec 1;16(23):6964–6976. doi: 10.1093/emboj/16.23.6964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Greenberg M. E., Iafrate A. J., Skowronski J. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 1998 May 15;17(10):2777–2789. doi: 10.1093/emboj/17.10.2777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Greenberg M., DeTulleo L., Rapoport I., Skowronski J., Kirchhausen T. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Curr Biol. 1998 Nov 5;8(22):1239–1242. doi: 10.1016/s0960-9822(07)00518-0. [DOI] [PubMed] [Google Scholar]
  29. Greenway A., Azad A., McPhee D. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J Virol. 1995 Mar;69(3):1842–1850. doi: 10.1128/jvi.69.3.1842-1850.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Grzesiek S., Bax A., Clore G. M., Gronenborn A. M., Hu J. S., Kaufman J., Palmer I., Stahl S. J., Wingfield P. T. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat Struct Biol. 1996 Apr;3(4):340–345. doi: 10.1038/nsb0496-340. [DOI] [PubMed] [Google Scholar]
  31. Grzesiek S., Bax A., Hu J. S., Kaufman J., Palmer I., Stahl S. J., Tjandra N., Wingfield P. T. Refined solution structure and backbone dynamics of HIV-1 Nef. Protein Sci. 1997 Jun;6(6):1248–1263. doi: 10.1002/pro.5560060613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Grzesiek S., Stahl S. J., Wingfield P. T., Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry. 1996 Aug 13;35(32):10256–10261. doi: 10.1021/bi9611164. [DOI] [PubMed] [Google Scholar]
  33. Hanna Z., Kay D. G., Rebai N., Guimond A., Jothy S., Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell. 1998 Oct 16;95(2):163–175. doi: 10.1016/s0092-8674(00)81748-1. [DOI] [PubMed] [Google Scholar]
  34. Harris M. P., Neil J. C. Myristoylation-dependent binding of HIV-1 Nef to CD4. J Mol Biol. 1994 Aug 12;241(2):136–142. doi: 10.1006/jmbi.1994.1483. [DOI] [PubMed] [Google Scholar]
  35. Hensley P. Defining the structure and stability of macromolecular assemblies in solution: the re-emergence of analytical ultracentrifugation as a practical tool. Structure. 1996 Apr 15;4(4):367–373. doi: 10.1016/s0969-2126(96)00042-1. [DOI] [PubMed] [Google Scholar]
  36. Howe A. Y., Jung J. U., Desrosiers R. C. Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J Virol. 1998 Dec;72(12):9827–9834. doi: 10.1128/jvi.72.12.9827-9834.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Iafrate A. J., Bronson S., Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 1997 Feb 17;16(4):673–684. doi: 10.1093/emboj/16.4.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Janin J., Chothia C. The structure of protein-protein recognition sites. J Biol Chem. 1990 Sep 25;265(27):16027–16030. [PubMed] [Google Scholar]
  39. Janin J., Rodier F. Protein-protein interaction at crystal contacts. Proteins. 1995 Dec;23(4):580–587. doi: 10.1002/prot.340230413. [DOI] [PubMed] [Google Scholar]
  40. Johnson M. L., Correia J. J., Yphantis D. A., Halvorson H. R. Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. Biophys J. 1981 Dec;36(3):575–588. doi: 10.1016/S0006-3495(81)84753-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Jones S., Thornton J. M. Analysis of protein-protein interaction sites using surface patches. J Mol Biol. 1997 Sep 12;272(1):121–132. doi: 10.1006/jmbi.1997.1234. [DOI] [PubMed] [Google Scholar]
  42. Kienzle N., Freund J., Kalbitzer H. R., Mueller-Lantzsch N. Oligomerization of the Nef protein from human immunodeficiency virus (HIV) type 1. Eur J Biochem. 1993 Jun 1;214(2):451–457. doi: 10.1111/j.1432-1033.1993.tb17941.x. [DOI] [PubMed] [Google Scholar]
  43. Kirchhoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med. 1995 Jan 26;332(4):228–232. doi: 10.1056/NEJM199501263320405. [DOI] [PubMed] [Google Scholar]
  44. Klemm J. D., Schreiber S. L., Crabtree G. R. Dimerization as a regulatory mechanism in signal transduction. Annu Rev Immunol. 1998;16:569–592. doi: 10.1146/annurev.immunol.16.1.569. [DOI] [PubMed] [Google Scholar]
  45. Le Gall S., Erdtmann L., Benichou S., Berlioz-Torrent C., Liu L., Benarous R., Heard J. M., Schwartz O. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity. 1998 Apr;8(4):483–495. doi: 10.1016/s1074-7613(00)80553-1. [DOI] [PubMed] [Google Scholar]
  46. Lee C. H., Leung B., Lemmon M. A., Zheng J., Cowburn D., Kuriyan J., Saksela K. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 1995 Oct 16;14(20):5006–5015. doi: 10.1002/j.1460-2075.1995.tb00183.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lee C. H., Saksela K., Mirza U. A., Chait B. T., Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell. 1996 Jun 14;85(6):931–942. doi: 10.1016/s0092-8674(00)81276-3. [DOI] [PubMed] [Google Scholar]
  48. Liu L. X., Heveker N., Fackler O. T., Arold S., Le Gall S., Janvier K., Peterlin B. M., Dumas C., Schwartz O., Benichou S. Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J Virol. 2000 Jun;74(11):5310–5319. doi: 10.1128/jvi.74.11.5310-5319.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Liu L. X., Margottin F., Le Gall S., Schwartz O., Selig L., Benarous R., Benichou S. Binding of HIV-1 Nef to a novel thioesterase enzyme correlates with Nef-mediated CD4 down-regulation. J Biol Chem. 1997 May 23;272(21):13779–13785. doi: 10.1074/jbc.272.21.13779. [DOI] [PubMed] [Google Scholar]
  50. Lo Conte L., Chothia C., Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol. 1999 Feb 5;285(5):2177–2198. doi: 10.1006/jmbi.1998.2439. [DOI] [PubMed] [Google Scholar]
  51. Manninen A., Hiipakka M., Vihinen M., Lu W., Mayer B. J., Saksela K. SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology. 1998 Oct 25;250(2):273–282. doi: 10.1006/viro.1998.9381. [DOI] [PubMed] [Google Scholar]
  52. Mariani R., Kirchhoff F., Greenough T. C., Sullivan J. L., Desrosiers R. C., Skowronski J. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol. 1996 Nov;70(11):7752–7764. doi: 10.1128/jvi.70.11.7752-7764.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Miller M. D., Feinberg M. B., Greene W. C. The HIV-1 nef gene acts as a positive viral infectivity factor. Trends Microbiol. 1994 Aug;2(8):294–298. doi: 10.1016/0966-842x(94)90007-8. [DOI] [PubMed] [Google Scholar]
  54. Miller M. D., Warmerdam M. T., Ferrell S. S., Benitez R., Greene W. C. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity. Virology. 1997 Aug 4;234(2):215–225. doi: 10.1006/viro.1997.8641. [DOI] [PubMed] [Google Scholar]
  55. Nicholls A., Sharp K. A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 1991;11(4):281–296. doi: 10.1002/prot.340110407. [DOI] [PubMed] [Google Scholar]
  56. Owen D. J., Evans P. R. A structural explanation for the recognition of tyrosine-based endocytotic signals. Science. 1998 Nov 13;282(5392):1327–1332. doi: 10.1126/science.282.5392.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Pandori M. W., Fitch N. J., Craig H. M., Richman D. D., Spina C. A., Guatelli J. C. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J Virol. 1996 Jul;70(7):4283–4290. doi: 10.1128/jvi.70.7.4283-4290.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Piguet V., Chen Y. L., Mangasarian A., Foti M., Carpentier J. L., Trono D. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J. 1998 May 1;17(9):2472–2481. doi: 10.1093/emboj/17.9.2472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Piguet V., Gu F., Foti M., Demaurex N., Gruenberg J., Carpentier J. L., Trono D. Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell. 1999 Apr 2;97(1):63–73. doi: 10.1016/s0092-8674(00)80715-1. [DOI] [PubMed] [Google Scholar]
  60. Rossi F., Gallina A., Milanesi G. Nef-CD4 physical interaction sensed with the yeast two-hybrid system. Virology. 1996 Mar 1;217(1):397–403. doi: 10.1006/viro.1996.0130. [DOI] [PubMed] [Google Scholar]
  61. Saksela K., Cheng G., Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 1995 Feb 1;14(3):484–491. doi: 10.1002/j.1460-2075.1995.tb07024.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Sawai E. T., Khan I. H., Montbriand P. M., Peterlin B. M., Cheng-Mayer C., Luciw P. A. Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr Biol. 1996 Nov 1;6(11):1519–1527. doi: 10.1016/s0960-9822(96)00757-9. [DOI] [PubMed] [Google Scholar]
  63. Schorr J., Kellner R., Fackler O., Freund J., Konvalinka J., Kienzle N., Kräusslich H. G., Mueller-Lantzsch N., Kalbitzer H. R. Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases. J Virol. 1996 Dec;70(12):9051–9054. doi: 10.1128/jvi.70.12.9051-9054.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Schwartz O., Maréchal V., Danos O., Heard J. M. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J Virol. 1995 Jul;69(7):4053–4059. doi: 10.1128/jvi.69.7.4053-4059.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Schwartz O., Maréchal V., Le Gall S., Lemonnier F., Heard J. M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med. 1996 Mar;2(3):338–342. doi: 10.1038/nm0396-338. [DOI] [PubMed] [Google Scholar]
  66. Welker R., Kottler H., Kalbitzer H. R., Kräusslich H. G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology. 1996 May 1;219(1):228–236. doi: 10.1006/viro.1996.0240. [DOI] [PubMed] [Google Scholar]
  67. Wen J., Arakawa T., Philo J. S. Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions. Anal Biochem. 1996 Sep 5;240(2):155–166. doi: 10.1006/abio.1996.0345. [DOI] [PubMed] [Google Scholar]
  68. Wiskerchen M., Cheng-Mayer C. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. Virology. 1996 Oct 1;224(1):292–301. doi: 10.1006/viro.1996.0531. [DOI] [PubMed] [Google Scholar]
  69. Wray V., Mertins D., Kiess M., Henklein P., Trowitzsch-Kienast W., Schubert U. Solution structure of the cytoplasmic domain of the human CD4 glycoprotein by CD and 1H NMR spectroscopy: implications for biological functions. Biochemistry. 1998 Jun 9;37(23):8527–8538. doi: 10.1021/bi9723111. [DOI] [PubMed] [Google Scholar]
  70. Wu H., Kwong P. D., Hendrickson W. A. Dimeric association and segmental variability in the structure of human CD4. Nature. 1997 May 29;387(6632):527–530. doi: 10.1038/387527a0. [DOI] [PubMed] [Google Scholar]
  71. Xu X. N., Laffert B., Screaton G. R., Kraft M., Wolf D., Kolanus W., Mongkolsapay J., McMichael A. J., Baur A. S. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med. 1999 May 3;189(9):1489–1496. doi: 10.1084/jem.189.9.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES